Next to plants, bacteria account for most of the biomass on Earth. They are found everywhere, although certain species thrive only in specific ecological niches. These microorganisms biosynthesize a plethora of both primary and secondary metabolites, defined, respectively, as those required for the growth and maintenance of cellular functions and those not required for survival but offering a selective advantage for the producer under certain conditions. As a result, bacterial fermentation has long been used to manufacture valuable natural products of nutritional, agrochemical and pharmaceutical interest. The interactions of secondary metabolites with their biological targets have been optimized by millions of years of evolution and they are, thus, considered to be privileged chemical structures, not only for drug discovery. During the last two decades, functional genomics has allowed for an in-depth understanding of the underlying biosynthetic logic of secondary metabolites. This has, in turn, paved the way for the unprecedented use of bacteria as programmable biochemical workhorses. In this Review, we discuss the multifaceted use of bacteria as biological factories in diverse applications and highlight recent advances in targeted genetic engineering of bacteria for the production of valuable bioactive compounds. Emphasis is on current advances to access nature’s abundance of natural products.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Characterization and engineering of Streptomyces griseofuscus DSM 40191 as a potential host for heterologous expression of biosynthetic gene clusters
Scientific Reports Open Access 15 September 2021
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Bar-On, Y. M., Phillips, R. & Milo, R. The biomass distribution on Earth. Proc. Natl Acad. Sci. USA 115, 6506–6511 (2018).
Delgado-Baquerizo, M. et al. A global atlas of the dominant bacteria found in soil. Science 359, 320–325 (2018).
Staley, J. T. Domain Cell Theory supports the independent evolution of the Eukarya, Bacteria and Archaea and the Nuclear Compartment Commonality hypothesis. Open Biol. 7, 170041 (2017).
Schmidt, E. W. Trading molecules and tracking targets in symbiotic interactions. Nat. Chem. Biol. 4, 466–473 (2008).
Hoffmann, T. et al. Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria. Nat. Commun. 9, 803 (2018).
Over, B. et al. Natural-product-derived fragments for fragment-based ligand discovery. Nat. Chem. 5, 21–28 (2013).
All natural. Nat. Chem. Biol. 3, 351 (2007).
Sankaran, S., Zhao, S., Muth, C., Paez, J. & del Campo, A. Toward light-regulated living biomaterials. Adv. Sci. 5, 1800383 (2018).
Bose, A., Gardel, E. J., Vidoudez, C., Parra, E. A. & Girguis, P. R. Electron uptake by iron-oxidizing phototrophic bacteria. Nat. Commun. 5, 3391 (2014).
Sakimoto, K. K., Wong, A. B. & Yang, P. Self-photosensitization of nonphotosynthetic bacteria for solar-to-chemical production. Science 351, 74–77 (2016).
Shipman, S. L., Nivala, J., Macklis, J. D. & Church, G. M. CRISPR–Cas encoding of a digital movie into the genomes of a population of living bacteria. Nature 547, 345–349 (2017).
Din, M. O. et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536, 81–85 (2016).
Nguyen, P. Q., Botyanszki, Z., Tay, P. K. R. & Joshi, N. S. Programmable biofilm-based materials from engineered curli nanofibres. Nat. Commun. 5, 4945 (2014).
Yoshida, S. et al. A bacterium that degrades and assimilates poly(ethylene terephthalate). Science 351, 1196–1199 (2016).
Lin, P. et al. PC, a novel oral insecticidal toxin from Bacillus bombysepticus involved in host lethality via APN and BtR-175. Sci. Rep. 5, 11101 (2015).
Ruiu, L. et al. Pathogenicity and characterization of a novel Bacillus cereus sensu lato isolate toxic to the Mediterranean fruit fly Ceratitis capitata Wied. J. Invertebr. Pathol. 126, 71–77 (2015).
Mullins, A. J. et al. Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifaria. Nat. Microbiol. 4, 996–1005 (2019).
Rodrigues, A. et al. Variability of non-mutualistic filamentous fungi associated with Atta sexdens rubropilosa nests. Folia Microbiol. 50, 421 (2005).
Rodrigues, A., Bacci, M. Jr, Mueller, U. G., Ortiz, A. & Pagnocca, F. C. Microfungal “weeds” in the leafcutter ant symbiosis. Microb. Ecol. 56, 604–614 (2008).
Moayyedi, P. et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59, 325–332 (2010).
Oh, D.-C., Poulsen, M., Currie, C. R. & Clardy, J. Dentigerumycin: a bacterial mediator of an ant-fungus symbiosis. Nat. Chem. Biol. 5, 391–393 (2009).
Chevrette, M. G. et al. The antimicrobial potential of Streptomyces from insect microbiomes. Nat. Commun. 10, 516 (2019).
Tianero, M. D., Balaich, J. N. & Donia, M. S. Localized production of defence chemicals by intracellular symbionts of Haliclona sponges. Nat. Microbiol. 4, 1149–1159 (2019).
Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392–400 (2018). This review focuses on the challenges to connect the human microbiome to diseases and, finally, to enable more effective diagnosis, treatment and preventive modalities.
Milshteyn, A., Colosimo, D. A. & Brady, S. F. Accessing bioactive natural products from the human microbiome. Cell Host Microbe 23, 725–736 (2018).
Donia, M. S. et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158, 1402–1414 (2014).
Hsieh, M.-C. et al. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Sci. Rep. 8, 16791 (2018).
Jang, S.-E., Jeong, J.-J., Kim, J.-K., Han, M. J. & Kim, D.-H. Simultaneous amelioratation of colitis and liver injury in mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27. Sci. Rep. 8, 7500 (2018).
Alfaleh, K., Anabrees, J., Bassler, D. & Al-Kharfi, T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 3, CD005496 (2011).
Johnsen, P. H. et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol. Hepatol. 3, 17–24 (2018).
Park, M., Tsai, S.-L. & Chen, W. Microbial biosensors: engineered microorganisms as the sensing machinery. Sensors 13, 5777–5795 (2013).
Blakemore, R. Magnetotactic bacteria. Science 190, 377–379 (1975).
Vargas, G. et al. Applications of magnetotactic bacteria, magnetosomes and magnetosome crystals in biotechnology and nanotechnology: mini-review. Molecules 23, 2438 (2018).
Lower, B. H. & Bazylinski, D. A. The bacterial magnetosome: a unique prokaryotic organelle. J. Mol. Microbiol. Biotechnol. 23, 63–80 (2013).
Felfoul, O. et al. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nat. Nanotechnol. 11, 941–947 (2016).
Anbu, P., Kang, C.-H., Shin, Y.-J. & So, J.-S. Formations of calcium carbonate minerals by bacteria and its multiple applications. SpringerPlus 5, 250 (2016).
Tanaka, M. et al. Biomagnetic recovery and bioaccumulation of selenium granules in magnetotactic bacteria. Appl. Environ. Microbiol. 82, 3886–3891 (2016).
Zhou, Y. et al. Genetic improvement of Magnetospirillum gryphiswaldense for enhanced biological removal of phosphate. Biotechnol. Lett. 39, 1509–1514 (2017).
Smit, B. A. et al. Magnetotactic bacteria used to generate electricity based on Faraday’s law of electromagnetic induction. Lett. Appl. Microbiol. 66, 362–367 (2018).
Blondeau, M. et al. Magnetic-field induced rotation of magnetosome chains in silicified magnetotactic bacteria. Sci. Rep. 8, 7699 (2018).
Pierce, C. J. et al. Tuning bacterial hydrodynamics with magnetic fields. Phys. Rev. E 95, 62612 (2017).
Kolinko, I. et al. Biosynthesis of magnetic nanostructures in a foreign organism by transfer of bacterial magnetosome gene clusters. Nat. Nanotechnol. 9, 193–197 (2014). The functional transfer of the bacterial magnetosome gene cluster originating from Magnetospirillum gryphiswaldense MSR-1 into a foreign non-MTB might set the stage for synthetic-biology approaches to be utilized for diverse nanotechnological and biomedical applications.
Frankel, R. B., Bazylinski, D. A., Johnson, M. S. & Taylor, B. L. Magneto-aerotaxis in marine coccoid bacteria. Biophys. J. 73, 994–1000 (1997).
Bazylinski, D. A. et al. Magnetococcus marinus gen. nov., sp. nov., a marine, magnetotactic bacterium that represents a novel lineage (Magnetococcaceae fam. nov., Magnetococcales ord. nov.) at the base of the Alphaproteobacteria. Int. J. Syst. Evol. Microbiol. 63, 801–808 (2013).
Malyshev, D. A. et al. A semi-synthetic organism with an expanded genetic alphabet. Nature 509, 385–388 (2014).
Rovner, A. J. et al. Recoded organisms engineered to depend on synthetic amino acids. Nature 518, 89–93 (2015).
Mandell, D. J. et al. Biocontainment of genetically modified organisms by synthetic protein design. Nature 518, 55–60 (2015).
Wegmann, U., Carvalho, A. L., Stocks, M. & Carding, S. R. Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect. Sci. Rep. 7, 2294 (2017).
Gupta, P. L., Rajput, M., Oza, T., Trivedi, U. & Sanghvi, G. Eminence of microbial products in cosmetic industry. Nat. Prod. Bioprospect. 9, 267–278 (2019).
Becker, J., Rohles, C. M. & Wittmann, C. Metabolically engineered Corynebacterium glutamicum for bio-based production of chemicals, fuels, materials, and healthcare products. Metab. Eng. 50, 122–141 (2018).
Becker, J., Zelder, O., Häfner, S., Schröder, H. & Wittmann, C. From zero to hero — design-based systems metabolic engineering of Corynebacterium glutamicum for l-lysine production. Metab. Eng. 13, 159–168 (2011).
Li, Y. et al. Metabolic engineering of Corynebacterium glutamicum for methionine production by removing feedback inhibition and increasing NADPH level. Antonie van Leeuwenhoek 109, 1185–1197 (2016).
Yin, L. et al. Co-expression of feedback-resistant threonine dehydratase and acetohydroxy acid synthase increase l-isoleucine production in Corynebacterium glutamicum. Metab. Eng. 14, 542–550 (2012).
Liao, J. C., Mi, L., Pontrelli, S. & Luo, S. Fuelling the future: microbial engineering for the production of sustainable biofuels. Nat. Rev. Microbiol. 14, 288–304 (2016).
Li, T., Zhang, C., Yang, K.-L. & He, J. Unique genetic cassettes in a Thermoanaerobacterium contribute to simultaneous conversion of cellulose and monosugars into butanol. Sci. Adv. 4, e1701475 (2018).
Raveendran, S. et al. Applications of microbial enzymes in food industry. Food Technol. Biotechnol. 56, 16–30 (2018).
de Souza, P. M. & de Oliveira Magalhães, P. Application of microbial α-amylase in industry – A review. Braz. J. Microbiol. 41, 850–861 (2010).
Bowen, C. H. et al. Recombinant spidroins fully replicate primary mechanical properties of natural spider silk. Biomacromolecules 19, 3853–3860 (2018).
Harvey, D., Bardelang, P., Goodacre, S. L., Cockayne, A. & Thomas, N. R. Antibiotic spider silk: site-specific functionalization of recombinant spider silk using “click” chemistry. Adv. Mater. 29, 1604245 (2017).
Jafari, M. et al. Acidophilic bioleaching: a review on the process and effect of organic–inorganic reagents and materials on its efficiency. Min. Proc. Ext. Met. Rev. 40, 87–107 (2019).
Litchfield, C. Thirty years and counting: bioremediation in its prime? BioScience 55, 273–279 (2005).
Dixit, R. et al. Bioremediation of heavy metals from soil and aquatic environment: an overview of principles and criteria of fundamental processes. Sustainability 7, 2189–2212 (2015).
Flemming, H.-C. et al. Biofilms: an emergent form of bacterial life. Nat. Rev. Microbiol. 14, 563–575 (2016).
Hwang, H. G., Kim, M. S., Shin, S. M. & Hwang, C. W. Risk assessment of the schmutzdecke of biosand filters: identification of an opportunistic pathogen in schmutzdecke developed by an unsafe water source. Int. J. Environ. Res. Public Health 11, 2033–2048 (2014).
Chen, A. Y. et al. Synthesis and patterning of tunable multiscale materials with engineered cells. Nat. Mater. 13, 515–523 (2014).
Payne, S. et al. Temporal control of self-organized pattern formation without morphogen gradients in bacteria. Mol. Syst. Biol. 9, 697 (2013).
Cao, Y. et al. Programmable assembly of pressure sensors using pattern-forming bacteria. Nat. Biotechnol. 35, 1087–1093 (2017).
Kylilis, N. et al. Whole-cell biosensor with tunable limit of detection enables low-cost agglutination assays for medical diagnostic applications. ACS Sens. 4, 370–378 (2019).
Nguyen, P. Q., Courchesne, N.-M. D., Duraj-Thatte, A., Praveschotinunt, P. & Joshi, N. S. Engineered living materials: prospects and challenges for using biological systems to direct the assembly of smart materials. Adv. Mater. 30, 1704847 (2018).
Sawa, M. et al. Electricity generation from digitally printed cyanobacteria. Nat. Commun. 8, 1327 (2017).
Pungrasmi, W., Intarasoontron, J., Jongvivatsakul, P. & Likitlersuang, S. Evaluation of microencapsulation techniques for MICP bacterial spores applied in self-healing concrete. Sci. Rep. 9, 12484 (2019).
Wang, W. et al. Harnessing the hygroscopic and biofluorescent behaviors of genetically tractable microbial cells to design biohybrid wearables. Sci. Adv. 3, e1601984 (2017).
Williams, D. H., Stone, M. J., Hauck, P. R. & Rahman, S. K. Why are secondary metabolites (natural products) biosynthesized? J. Nat. Prod. 52, 1189–1208 (1989).
Schulz, S. & Dickschat, J. S. Bacterial volatiles: the smell of small organisms. Nat. Prod. Rep. 24, 814–842 (2007).
Freeman, M. F., Vagstad, A. L. & Piel, J. Polytheonamide biosynthesis showcasing the metabolic potential of sponge-associated uncultivated ‘Entotheonella’ bacteria. Curr. Opin. Chem. Biol. 31, 8–14 (2016).
Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615–2623 (2002).
Reymond, J.-L. & Awale, M. Exploring chemical space for drug discovery using the chemical universe database. ACS Chem. Neurosci. 3, 649–657 (2012).
Rodrigues, T., Reker, D., Schneider, P. & Schneider, G. Counting on natural products for drug design. Nat. Chem. 8, 531–541 (2016).
Schneider, P. & Schneider, G. Privileged structures revisited. Angew. Chem. Int. Ed. 56, 7971–7974 (2017).
Henkel, T., Brunne, R. M., Müller, H. & Reichel, F. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew. Chem. Int. Ed. 38, 643–647 (1999).
Herrmann, J., Fayad, A. A. & Müller, R. Natural products from myxobacteria: novel metabolites and bioactivities. Nat. Prod. Rep. 34, 135–160 (2017).
Genilloud, O. Actinomycetes: still a source of novel antibiotics. Nat. Prod. Rep. 34, 1203–1232 (2017).
Fujiwara, A., Hoshino, T. & Westley, J. W. Anthracycline antibiotics. Crit. Rev. Biotechnol. 3, 133–157 (1985).
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Cytotoxic Antibiotics (National Institute of Diabetes and Digestive and Kidney Diseases, 2012).
La Clair, J. J. Natural product mode of action (MOA) studies: a link between natural and synthetic worlds. Nat. Prod. Rep. 27, 969–995 (2010).
Kling, A. et al. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science 348, 1106–1112 (2015).
Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111–129 (2015).
Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3–25 (2001).
Benet, L. Z., Hosey, C. M., Ursu, O. & Oprea, T. I. BDDCS, the rule of 5 and drugability. Adv. Drug Deliv. Rev. 101, 89–98 (2016).
Koch, M. A. et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl Acad. Sci. USA 102, 17272–17277 (2005).
Molnar, I. et al. The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem. Biol. 7, 97–109 (2000).
Chen, H. & Du, L. Iterative polyketide biosynthesis by modular polyketide synthases in bacteria. Appl. Microbiol. Biotechnol. 100, 541–557 (2016).
Zhang, Z., Pan, H.-X. & Tang, G.-L. New insights into bacterial type II polyketide biosynthesis. F1000Research 6, 172 (2017).
Lim, Y. P., Go, M. K. & Yew, W. S. Exploiting the biosynthetic potential of type III polyketide synthases. Molecules 21, 806 (2016).
Dickschat, J. S. Bacterial terpene cyclases. Nat. Prod. Rep. 33, 87–110 (2016).
Ortega, M. A. & van der Donk, W. A. New insights into the biosynthetic logic of ribosomally synthesized and post-translationally modified peptide natural products. Cell Chem. Biol. 23, 31–44 (2016).
Inoue, M. et al. Total synthesis of the large non-ribosomal peptide polytheonamide B. Nat. Chem. 2, 280–285 (2010).
Arnison, P. G. et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 30, 108–160 (2013).
Oman, T. J. & van der Donk, W. A. Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat. Chem. Biol. 6, 9–18 (2010).
Jordan, P. A. & Moore, B. S. Biosynthetic pathway connects cryptic ribosomally synthesized posttranslationally modified peptide genes with pyrroloquinoline alkaloids. Cell Chem. Biol. 23, 1504–1514 (2016).
Ting, C. P. et al. Use of a scaffold peptide in the biosynthesis of amino acid–derived natural products. Science 365, 280–284 (2019).
Fang, H., Kang, J. & Zhang, D. Microbial production of vitamin B12: a review and future perspectives. Microb. Cell Fact. 16, 15 (2017).
Scott, T. A. & Piel, J. The hidden enzymology of bacterial natural product biosynthesis. Nat. Rev. Chem. 3, 404–425 (2019).
Okada, B. K. & Seyedsayamdost, M. R. Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules. FEMS Microbiol. Rev. 41, 19–33 (2017).
Rutledge, P. J. & Challis, G. L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 13, 509–523 (2015).
Onaka, H., Mori, Y., Igarashi, Y. & Furumai, T. Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species. Appl. Environ. Microbiol. 77, 400–406 (2011).
Moore, J. M., Bradshaw, E., Seipke, R. F., Hutchings, M. I. & McArthur, M. Use and discovery of chemical elicitors that stimulate biosynthetic gene clusters in Streptomyces bacteria. Methods Enzymol. 517, 367–385 (2012).
Seyedsayamdost, M. R. High-throughput platform for the discovery of elicitors of silent bacterial gene clusters. Proc. Natl Acad. Sci. USA 111, 7266–7271 (2014).
Locatelli, F. M., Goo, K.-S. & Ulanova, D. Effects of trace metal ions on secondary metabolism and the morphological development of streptomycetes. Metallomics 8, 469–480 (2016).
Hosaka, T. et al. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat. Biotechnol. 27, 462–464 (2009).
Tanaka, Y. et al. Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes. J. Bacteriol. 195, 2959–2970 (2013).
Ochi, K. & Hosaka, T. New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters. Appl. Microbiol. Biotechnol. 97, 87–98 (2013).
Li, X., Wu, X., Zhu, J. & Shen, Y. Amexanthomycins A–J, pentangular polyphenols produced by Amycolatopsis mediterranei S699∆rifA. Appl. Microbiol. Biotechnol. 102, 689–702 (2018).
Rebets, Y., Brötz, E., Tokovenko, B. & Luzhetskyy, A. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo? J. Ind. Microbiol. Biotechnol. 41, 387–402 (2014).
Rigali, S., Anderssen, S., Naômé, A. & van Wezel, G. P. Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery. Biochem. Pharmacol. 153, 24–34 (2018).
Panter, F., Krug, D., Baumann, S. & Müller, R. Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria. Chem. Sci. 9, 4898–4908 (2018). In silico analysis for genes encoding a functional biosynthetic machinery co-localized with host self-resistance led to the discovery of a silent type II PKS BGC in Pyxidicoccus fallax An d48 and, after its activation, to the isolation of novel topoisomerase inhibitors.
Zerikly, M. & Challis, G. L. Strategies for the discovery of new natural products by genome mining. ChemBioChem 10, 625–632 (2009).
Laureti, L. et al. Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc. Natl Acad. Sci. USA 108, 6258–6263 (2011).
Sidda, J. D. et al. Discovery of a family of γ-aminobutyrate ureas via rational derepression of a silent bacterial gene cluster. Chem. Sci. 5, 86–89 (2014).
Wang, B., Guo, F., Dong, S.-H. & Zhao, H. Activation of silent biosynthetic gene clusters using transcription factor decoys. Nat. Chem. Biol. 15, 111–114 (2019).
Huo, L., Rachid, S., Stadler, M., Wenzel, S. C. & Müller, R. Synthetic biotechnology to study and engineer ribosomal bottromycin biosynthesis. Chem. Biol. 19, 1278–1287 (2012).
Seegers, C. L. C., Setroikromo, R. & Quax, W. J. in Natural Products and Cancer Drug Discovery (ed. Badria, F. A.) (InTech, 2017).
Kung, S. H., Lund, S., Murarka, A., McPhee, D. & Paddon, C. J. Approaches and recent developments for the commercial production of semi-synthetic artemisinin. Front. Plant. Sci. 9, 87 (2018).
Paddon, C. J. & Keasling, J. D. Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat. Rev. Microbiol. 12, 355–367 (2014).
Paddon, C. J. et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496, 528–532 (2013).
Huo, L. et al. Heterologous expression of bacterial natural product biosynthetic pathways. Nat. Prod. Rep. 36, 1412–1436 (2019).
Wenzel, S. C. & Müller, R. Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways. Curr. Opin. Biotechnol. 16, 594–606 (2005).
Horbal, L., Siegl, T. & Luzhetskyy, A. A set of synthetic versatile genetic control elements for the efficient expression of genes in Actinobacteria. Sci. Rep. 8, 491 (2018).
Horbal, L. & Luzhetskyy, A. Dual control system–A novel scaffolding architecture of an inducible regulatory device for the precise regulation of gene expression. Metab. Eng. 37, 11–23 (2016).
Horbal, L., Fedorenko, V. & Luzhetskyy, A. Novel and tightly regulated resorcinol and cumate-inducible expression systems for Streptomyces and other actinobacteria. Appl. Microbiol. Biotechnol. 98, 8641–8655 (2014).
Sanchez-Garcia, L. et al. Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb. Cell Fact. 15, 33 (2016).
Baeshen, N. A. et al. Cell factories for insulin production. Microb. Cell Fact. 13, 141 (2014).
Folkman, J. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action. Exp. Cell Res. 312, 594–607 (2006).
Babaeipour, V., Khanchezar, S., Mofid, M. R. & Pesaran Hagi Abbas, M. Efficient process development of recombinant human granulocyte colony-stimulating factor (rh-GCSF) production in Escherichia coli. Iran. Biomed. J. 19, 102–110 (2015).
Molineux, G. The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®). Curr. Pharm. Des. 10, 1235–1244 (2004).
Turturro, F. Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders. Expert Rev. Anticancer Ther. 7, 11–17 (2007).
Cai, X. et al. Entomopathogenic bacteria use multiple mechanisms for bioactive peptide library design. Nat. Chem. 9, 379–386 (2017).
Baltz, R. H. Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J. Ind. Microbiol. Biotechnol. 37, 759–772 (2010).
Pogorevc, D. et al. Biosynthesis and heterologous production of argyrins. ACS Synth. Biol. 8, 1121–1133 (2019).
Yan, F. et al. Biosynthesis and heterologous production of vioprolides: rational biosynthetic engineering and unprecedented 4-methylazetidinecarboxylic acid formation. Angew. Chem. Int. Ed. 57, 8754–8759 (2018).
Videau, P., Wells, K. N., Singh, A. J., Gerwick, W. H. & Philmus, B. Assessment of Anabaena sp. strain PCC 7120 as a heterologous expression host for cyanobacterial natural products: production of lyngbyatoxin A. ACS Synth. Biol. 5, 978–988 (2016).
Shang, J.-L. et al. UV-B induced biosynthesis of a novel sunscreen compound in solar radiation and desiccation tolerant cyanobacteria. Environ. Microbiol. 20, 200–213 (2018).
Yang, G. et al. Photosynthetic production of sunscreen shinorine using an engineered cyanobacterium. ACS Synth. Biol. 7, 664–671 (2018).
Roulet, J. et al. Development of a cyanobacterial heterologous polyketide production platform. Metab. Eng. 49, 94–104 (2018).
Agarwal, V. et al. Metagenomic discovery of polybrominated diphenyl ether biosynthesis by marine sponges. Nat. Chem. Biol. 13, 537–543 (2017).
Zhang, J. J., Tang, X. & Moore, B. S. Genetic platforms for heterologous expression of microbial natural products. Nat. Prod. Rep. 36, 1313–1332 (2019).
Gemperlein, K., Zipf, G., Bernauer, H. S., Müller, R. & Wenzel, S. C. Metabolic engineering of Pseudomonas putida for production of docosahexaenoic acid based on a myxobacterial PUFA synthase. Metab. Eng. 33, 98–108 (2016).
Li, Y. et al. Directed natural product biosynthesis gene cluster capture and expression in the model bacterium Bacillus subtilis. Sci. Rep. 5, 9383 (2015).
Liu, Q. et al. Simple and rapid direct cloning and heterologous expression of natural product biosynthetic gene cluster in Bacillus subtilis via Red/ET recombineering. Sci. Rep. 6, 34623 (2016).
Borrero, J. et al. Plantaricyclin A, a novel circular bacteriocin produced by Lactobacillus plantarum NI326: purification, characterization, and heterologous production. Appl. Environ. Microbiol. 84, e01801-17 (2018).
Daba, G. M., Ishibashi, N., Zendo, T. & Sonomoto, K. Functional analysis of the biosynthetic gene cluster required for immunity and secretion of a novel Lactococcus-specific bacteriocin, lactococcin Z. J. Appl. Microbiol. 123, 1124–1132 (2017).
Bian, X. et al. Heterologous production and yield improvement of epothilones in Burkholderiales strain DSM 7029. ACS Chem. Biol. 12, 1805–1812 (2017).
Zhang, J. J., Moore, B. S. & Tang, X. Engineering Salinispora tropica for heterologous expression of natural product biosynthetic gene clusters. Appl. Microbiol. Biotechnol. 102, 8437–8446 (2018).
Sasse, F. et al. Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties. J. Antibiot. 55, 543–551 (2002).
Vollbrecht, L. et al. Argyrins, immunosuppressive cyclic peptides from myxobacteria. II. Structure elucidation and stereochemistry. J. Antibiot. 55, 715–721 (2002).
Ferrari, P. et al. Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. II. Structure elucidation. J. Antibiot. 49, 150–154 (1996).
Selva, E. et al. Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. I. Taxonomy, isolation and characterization. J. Antibiot. 49, 145–149 (1996).
Gemperlein, K. et al. Polyunsaturated fatty acid production by Yarrowia lipolytica employing designed myxobacterial PUFA synthases. Nat. Commun. 10, 4055 (2019).
Lenihan-Geels, G., Bishop, K. S. & Ferguson, L. R. Alternative sources of omega-3 fats: can we find a sustainable substitute for fish? Nutrients 5, 1301–1315 (2013).
Myronovskyi, M. et al. Generation of a cluster-free Streptomyces albus chassis strains for improved heterologous expression of secondary metabolite clusters. Metab. Eng. 49, 316–324 (2018).
Wang, L., Ravichandran, V., Yin, Y., Yin, J. & Zhang, Y. Natural products from mammalian gut microbiota. Trends Biotechnol. 37, 492–504 (2019).
Dabard, J. et al. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl. Environ. Microbiol. 67, 4111–4118 (2001).
Hatziioanou, D. et al. Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract. Microbiology 163, 1292–1305 (2017).
Dornisch, E. et al. Biosynthesis of the enterotoxic pyrrolobenzodiazepine natural product tilivalline. Angew. Chem. Int. Ed. 56, 14753–14757 (2017).
Schneditz, G. et al. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis. Proc. Natl Acad. Sci. USA 111, 13181–13186 (2014).
von Tesmar, A. et al. Biosynthesis of the Klebsiella oxytoca pathogenicity factor tilivalline: heterologous expression, in vitro biosynthesis, and inhibitor development. ACS Chem. Biol. 13, 812–819 (2018).
Hover, B. M. et al. Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens. Nat. Microbiol. 3, 415–422 (2018).
Smith, T. E. et al. Accessing chemical diversity from the uncultivated symbionts of small marine animals. Nat. Chem. Biol. 14, 179–185 (2018).
Nasrin, S. et al. Chloramphenicol derivatives with antibacterial activity identified by functional metagenomics. J. Nat. Prod. 81, 1321–1332 (2018).
Hussain, M. S. et al. Current approaches toward production of secondary plant metabolites. J. Pharm. Bioallied Sci. 4, 10–20 (2012).
Azmir, J. et al. Techniques for extraction of bioactive compounds from plant materials: A review. J. Food Eng. 117, 426–436 (2013).
Cravens, A., Payne, J. & Smolke, C. D. Synthetic biology strategies for microbial biosynthesis of plant natural products. Nat. Commun. 10, 2142 (2019).
Ochoa-Villarreal, M. et al. Plant cell culture strategies for the production of natural products. BMB Rep. 49, 149–158 (2016).
Smetanska, I. in Food Biotechnology. Advances in Biochemical Engineering/Biotechnology Vol. 111 (eds Stahl, U., Donalies, U. E. B. & Nevoigt, E.) 187–228 (Springer, 2008).
Mustafa, N. R., de Winter, W., van Iren, F. & Verpoorte, R. Initiation, growth and cryopreservation of plant cell suspension cultures. Nat. Protoc. 6, 715–742 (2011).
Kotopka, B. J., Li, Y. & Smolke, C. D. Synthetic biology strategies toward heterologous phytochemical production. Nat. Prod. Rep. 35, 902–920 (2018).
Luo, X. et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567, 123–126 (2019).
Nakagawa, A. et al. Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli. Nat. Commun. 7, 10390 (2016).
Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M. & Smolke, C. D. Complete biosynthesis of opioids in yeast. Science 349, 1095–1100 (2015). The first microbial production of the selected opioid compounds thebaine and hydrocodone starting from central metabolism.
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P. & McPhail, A. T. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93, 2325–2327 (1971).
Suffness, M. Taxol: Science and Applications (CRC, 1995).
Nicolaou, K. C. et al. Total synthesis of taxol. Nature 367, 630–634 (1994).
Holton, R. A. et al. First total synthesis of taxol. 1. Functionalization of the B ring. J. Am. Chem. Soc. 116, 1597–1598 (1994).
Doi, T. et al. A formal total synthesis of taxol aided by an automated synthesizer. Chem. Asian J. 1, 370–383 (2006).
Hirai, S., Utsugi, M., Iwamoto, M. & Nakada, M. Formal total synthesis of (−)-taxol through Pd-catalyzed eight-membered carbocyclic ring formation. Chem. Eur. J. 21, 355–359 (2015).
Expósito, O. et al. Biotechnological production of taxol and related taxoids: current state and prospects. Anticancer Agents Med. Chem. 9, 109–121 (2008).
Roberts, S. C. Production and engineering of terpenoids in plant cell culture. Nat. Chem. Biol. 3, 387–395 (2007).
Ajikumar, P. K. et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330, 70–74 (2010).
Biggs, B. W. et al. Overcoming heterologous protein interdependency to optimize P450-mediated Taxol precursor synthesis in Escherichia coli. Proc. Natl Acad. Sci. USA 113, 3209–3214 (2016).
Chang, M. C. Y., Eachus, R. A., Trieu, W., Ro, D.-K. & Keasling, J. D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat. Chem. Biol. 3, 274–277 (2007).
Dietrich, J. A. et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450BM3. ACS Chem. Biol. 4, 261–267 (2009).
Li, S., Li, Y. & Smolke, C. D. Strategies for microbial synthesis of high-value phytochemicals. Nat. Chem. 10, 395–404 (2018).
Zhou, K., Qiao, K., Edgar, S. & Stephanopoulos, G. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nat. Biotechnol. 33, 377–383 (2015).
Jones, J. A. et al. Experimental and computational optimization of an Escherichia coli co-culture for the efficient production of flavonoids. Metab. Eng. 35, 55–63 (2016).
Minami, H. et al. Microbial production of plant benzylisoquinoline alkaloids. Proc. Natl Acad. Sci. USA 105, 7393–7398 (2008).
Menon, B. R. K. & Jenner, M. Biosynthesis: Reprogramming assembly lines. Nat. Chem. 10, 245–247 (2018).
Williams, G. et al. in Developments in Biotechnology and Bioprocessing. ACS Symposium Series Vol. 1125 (eds Kantardjieff, A., Asuri, P., Coffman, J. L. & Jayapal, K.) 147–163 (American Chemical Society, 2013).
Shier, W. T., Rinehart, K. L. & Gottlieb, D. Preparation of four new antibiotics from a mutant of Streptomyces fradiae. Proc. Natl Acad. Sci. USA 63, 198–204 (1969).
Eichner, S., Floss, H. G., Sasse, F. & Kirschning, A. New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis. ChemBioChem 10, 1801–1805 (2009).
Knobloch, T. et al. Mutational biosynthesis of ansamitocin antibiotics: a diversity-oriented approach to exploit biosynthetic flexibility. ChemBioChem 12, 540–547 (2011).
Sahner, J. H. et al. Advanced mutasynthesis studies on the natural α-pyrone antibiotic myxopyronin from Myxococcus fulvus. ChemBioChem 16, 946–953 (2015).
Kries, H., Niquille, D. L. & Hilvert, D. A subdomain swap strategy for reengineering nonribosomal peptides. Chem. Biol. 22, 640–648 (2015).
Kim, E., Moore, B. S. & Yoon, Y. J. Reinvigorating natural product combinatorial biosynthesis with synthetic biology. Nat. Chem. Biol. 11, 649–659 (2015).
McDaniel, R., Ebert-Khosla, S., Hopwood, D. A. & Khosla, C. Engineered biosynthesis of novel polyketides. Science 262, 1546–1550 (1993).
McDaniel, R. et al. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel “unnatural” natural products. Proc. Natl Acad. Sci. USA 96, 1846–1851 (1999).
Nguyen, K. T. et al. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proc. Natl Acad. Sci. USA 103, 17462–17467 (2006). In this study, the authors established a robust combinatorial-biosynthesis platform to produce novel antibiotic peptides related to daptomycin at high yields.
Baltz, R. H. Combinatorial biosynthesis of cyclic lipopeptide antibiotics: A model for synthetic biology to accelerate the evolution of secondary metabolite biosynthetic pathways. ACS Synth. Biol. 3, 748–758 (2014).
Awakawa, T. et al. Reprogramming of the antimycin NRPS-PKS assembly lines inspired by gene evolution. Nat. Commun. 9, 3534 (2018).
Winn, M., Fyans, J. K., Zhuo, Y. & Micklefield, J. Recent advances in engineering nonribosomal peptide assembly lines. Nat. Prod. Rep. 33, 317–347 (2016).
Kries, H. Biosynthetic engineering of nonribosomal peptide synthetases. J. Pept. Sci. 22, 564–570 (2016).
Bozhüyük, K. A. J. et al. De novo design and engineering of non-ribosomal peptide synthetases. Nat. Chem. 10, 275–281 (2018). De novo design of NRPSs via a new strategy using defined exchange units and not modules as functional units.
Zhang, J. et al. Structural basis of nonribosomal peptide macrocyclization in fungi. Nat. Chem. Biol. 12, 1001–1003 (2016).
Gao, X. et al. Cyclization of fungal nonribosomal peptides by a terminal condensation-like domain. Nat. Chem. Biol. 8, 823–830 (2012).
Bozhüyük, K. A. J. et al. Modification and de novo design of non-ribosomal peptide synthetases using specific assembly points within condensation domains. Nat. Chem. 11, 653–661 (2019). The XUC concept enables the production of peptide libraries, functionalized xenotetrapeptides and the incorporation of non-natural amino acids via de novo design of NRPSs.
Medema, M. H., Cimermancic, P., Sali, A., Takano, E. & Fischbach, M. A. A systematic computational analysis of biosynthetic gene cluster evolution: lessons for engineering biosynthesis. PLoS Comput. Biol. 10, e1004016 (2014).
Chemler, J. A. et al. Evolution of efficient modular polyketide synthases by homologous recombination. J. Am. Chem. Soc. 137, 10603–10609 (2015).
Zeymer, C. & Hilvert, D. Directed evolution of protein catalysts. Annu. Rev. Biochem. 87, 131–157 (2018).
Kan, S. B. J., Lewis, R. D., Chen, K. & Arnold, F. H. Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life. Science 354, 1048–1051 (2016).
Lutz, S. Beyond directed evolution — semi-rational protein engineering and design. Curr. Opin. Biotechnol. 21, 734–743 (2010).
Niquille, D. L. et al. Nonribosomal biosynthesis of backbone-modified peptides. Nat. Chem. 10, 282–287 (2018).
Otten, L. G., Schaffer, M. L., Villiers, B. R. M., Stachelhaus, T. & Hollfelder, F. An optimized ATP/PPi-exchange assay in 96-well format for screening of adenylation domains for applications in combinatorial biosynthesis. Biotechnol. J. 2, 232–240 (2007).
Zhang, K. et al. Engineering the substrate specificity of the DhbE adenylation domain by yeast cell surface display. Chem. Biol. 20, 92–101 (2013).
Villiers, B. & Hollfelder, F. Directed evolution of a gatekeeper domain in nonribosomal peptide synthesis. Chem. Biol. 18, 1290–1299 (2011).
Kendrew, S. G. et al. Recombinant strains for the enhanced production of bioengineered rapalogs. Metab. Eng. 15, 167–173 (2013).
Wlodek, A. et al. Diversity oriented biosynthesis via accelerated evolution of modular gene clusters. Nat. Commun. 8, 1206 (2017). The production of different rapalogues was accomplished via an accelerated-evolution method of modular PKS genes mimicking a plausible mechanism of natural evolution.
Shi, D., Nannenga, B. L., Iadanza, M. G. & Gonen, T. Three-dimensional electron crystallography of protein microcrystals. elife 2, e01345 (2013).
Nannenga, B. L., Shi, D., Leslie, A. G. W. & Gonen, T. High-resolution structure determination by continuous-rotation data collection in MicroED. Nat. Methods 11, 927–930 (2014).
Jones, C. G. et al. The CryoEM method MicroED as a powerful tool for small molecule structure determination. ACS Cent. Sci. 4, 1587–1592 (2018).
Blin, K. et al. antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline. Nucleic Acids Res. 47, W81–W87 (2019).
Helfrich, E. J. N. et al. Automated structure prediction of trans-acyltransferase polyketide synthase products. Nat. Chem. Biol. 15, 813–821 (2019).
Wang, M. et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 34, 828–837 (2016).
We would like to acknowledge B. Schnell, D. Pogorevc and J. Dastbaz for their helpful comments on this manuscript. Research in R.M.’s laboratory is funded by the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF) and the Deutsches Zentrum für Infektionsforschung Standort Hannover-Braunschweig. Joachim J. Hug acknowledges funding by a PhD fellowship of the Boehringer Ingelheim Fonds.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Genetic region that initiates the transcription of a particular gene by binding RNA polymerase and transcription factors. Constitutive promoters are always active, while inducible promoters are regulated through molecules, temperature and light.
Isosteres are molecules or ions with similar chemical scaffold. This means the same number and arrangement of atoms and comparable electronic properties.
- Heterologous expression
The production of non-native biomolecules through the transfer of biosynthetic genes into a foreign host.
About this article
Cite this article
Hug, J.J., Krug, D. & Müller, R. Bacteria as genetically programmable producers of bioactive natural products. Nat Rev Chem 4, 172–193 (2020). https://doi.org/10.1038/s41570-020-0176-1
This article is cited by
Nature Chemical Biology (2022)
Characterization and engineering of Streptomyces griseofuscus DSM 40191 as a potential host for heterologous expression of biosynthetic gene clusters
Scientific Reports (2021)
Materials Circular Economy (2021)
Identification of the key functional genes in salt-stress tolerance of Cyanobacterium Phormidium tenue using in silico analysis
3 Biotech (2021)